Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 6 | 2026 | 267 | 1.150 |
Why?
|
| Brachytherapy | 4 | 2026 | 85 | 0.540 |
Why?
|
| Radiosurgery | 3 | 2026 | 148 | 0.470 |
Why?
|
| Patient Compliance | 1 | 2017 | 463 | 0.420 |
Why?
|
| Radiation Pneumonitis | 1 | 2012 | 11 | 0.380 |
Why?
|
| Protons | 1 | 2012 | 94 | 0.360 |
Why?
|
| Esophageal Neoplasms | 2 | 2012 | 384 | 0.340 |
Why?
|
| Chemoradiotherapy | 4 | 2022 | 124 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2026 | 229 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2026 | 587 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2026 | 349 | 0.170 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 40 | 0.160 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2020 | 38 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 71 | 0.150 |
Why?
|
| Analgesics | 1 | 2020 | 120 | 0.150 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 43 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 51 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2026 | 3742 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2026 | 1305 | 0.120 |
Why?
|
| Pneumonectomy | 1 | 2017 | 154 | 0.120 |
Why?
|
| Middle Aged | 8 | 2026 | 28315 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 902 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2026 | 17577 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1069 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 747 | 0.110 |
Why?
|
| Neoplasm Staging | 3 | 2026 | 1278 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1263 | 0.100 |
Why?
|
| Organs at Risk | 2 | 2026 | 48 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 356 | 0.100 |
Why?
|
| Radiotherapy Dosage | 2 | 2026 | 217 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 61 | 0.090 |
Why?
|
| Female | 11 | 2026 | 70342 | 0.090 |
Why?
|
| Quality of Life | 1 | 2022 | 2068 | 0.090 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2026 | 107 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2026 | 2057 | 0.090 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 122 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2012 | 108 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 197 | 0.080 |
Why?
|
| Age Factors | 1 | 2017 | 2824 | 0.080 |
Why?
|
| Proton Therapy | 1 | 2012 | 155 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 283 | 0.080 |
Why?
|
| Metformin | 1 | 2012 | 173 | 0.080 |
Why?
|
| Aged | 6 | 2026 | 20818 | 0.080 |
Why?
|
| Adult | 6 | 2026 | 31035 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 476 | 0.070 |
Why?
|
| Humans | 11 | 2026 | 130204 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1547 | 0.060 |
Why?
|
| Algorithms | 2 | 2026 | 1663 | 0.060 |
Why?
|
| Radiometry | 1 | 2026 | 49 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 968 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 6764 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 888 | 0.050 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2022 | 10 | 0.050 |
Why?
|
| Cystoscopy | 1 | 2022 | 41 | 0.040 |
Why?
|
| Safety-net Providers | 1 | 2022 | 89 | 0.040 |
Why?
|
| Promethazine | 1 | 2020 | 5 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2026 | 2076 | 0.040 |
Why?
|
| Hydromorphone | 1 | 2020 | 12 | 0.040 |
Why?
|
| Lorazepam | 1 | 2020 | 12 | 0.040 |
Why?
|
| Urban Population | 1 | 2022 | 284 | 0.040 |
Why?
|
| Antiemetics | 1 | 2020 | 22 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 41 | 0.040 |
Why?
|
| Radiography | 1 | 2022 | 740 | 0.040 |
Why?
|
| Rectum | 1 | 2020 | 102 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 70 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 348 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2020 | 218 | 0.040 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 16 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 274 | 0.040 |
Why?
|
| Veterans Health | 1 | 2017 | 170 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1481 | 0.030 |
Why?
|
| Male | 3 | 2017 | 64425 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1115 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6407 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2012 | 70 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 687 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1799 | 0.020 |
Why?
|
| Lung | 1 | 2017 | 1532 | 0.020 |
Why?
|
| United States | 1 | 2017 | 11959 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 10000 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12824 | 0.010 |
Why?
|